Browse studies

Find your next paid study

27,354 recruiting studies available now

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in the Treatment of Subjects With Metastatic Pancreatic Cancer

A Phase I, Open-Label, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of XNW28012 Monotherapy in …

Metastatic Pancreatic Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Evopoint Biosciences Inc.NCT07707674

Observational

Technology Assisted Treatment for Trichotillomania

The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.

Trichotillomania

Estimated

~$10 – $1,050

Actual pay is set by the research site.

HabitAware Inc.NCT05118633

The Arch Watch Study: An Integrated Evaluation of Hemodynamics During Monitoring of Ductus Arteriosus Closure in Infants With Suspected Coarctation of the Aorta

Unrecognized coarctation of the aorta (CoA) is a life-threatening component of congenital heart disease (CHD) in which narrowing of the aorta causes obstructed…

Coarctation of the AortaAortic Arch Obstruction

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT05880576

Phase 1

Phase 1/2 Study of REGN4336 (a PSMAxCD3 Bispecific Antibody) Administered Alone or in Combination With REGN5678 (a PSMAxCD28 Bispecific Antibody) in Patients With Metastatic Castration-Resistant Prostate Cancer

This study is researching an investigational drug called REGN4336 both alone or together with another investigational drug called REGN5678. The study is focuse…

Metastatic Castration-resistant Prostate Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT05125016

Phase 1

Evaluation of the Distribution of CM500 in Healthy Volunteers and Patients With Cancer

The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomo…

Bladder CancerGliomaGlioblastoma (GBM)+13 more

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Lumina Pharmaceuticals IncNCT07781852

Observational

Short-messaging Services (SMS) Text for Uncontrolled Diabetes Among Persons Experiencing Homelessness

This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods to assess the impact of a SMS text strategy in diabetes control am…

Diabetes Mellitus

Estimated

~$10 – $750

Actual pay is set by the research site.

George Washington UniversityNCT05616026

Phase 4

A Randomized Control Trial for Opioid Use After Laparoscopic Salpingectomy

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine i…

Opioid UsePost-operative PainSterility, Female

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Johns Hopkins UniversityNCT06434233

Phase 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)

Researchers want to know if intismeran autogene (the study treatment) given with pembrolizumab and chemotherapy can treat metastatic treatment-naive squamous n…

Squamous Non-small Cell Lung Cancer

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT07221474

Phase 1

A Phase 1, Open-Label, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetics of Casdatifan (AB521) in Participants With Moderate Hepatic Impairment Compared to Healthy Matched Participants

The purpose of the study is to compare the single dose PK of casdatifan between participants with moderate hepatic impairment (HI) and healthy matched control …

Healthy ParticipantsHepatic Impairment

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Arcus Biosciences, Inc.NCT07751250

The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain Injury

The NCTT is a prospective, multicenter, observational research network for subjects with chronic spinal cord and/or chronic traumatic brain injury.

Spinal Cord InjuryTraumatic Brain Injury

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT02769416

Healing ALS Registry Observational Study (HAROS)

This is a prospective, observational, online study of people diagnosed with ALS, MND or PLS referred to as HAROS (Healing ALS Registry Observational Study). Pa…

Amyotrophic Lateral Sclerosis (ALS)Motor Neuron Disease (MND)Primary Lateral Sclerosis (PLS)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Healing Advocates Registry and MinistryNCT07233148

Phase 2

A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?

Investigators will recruit 36 individuals on MAT for OUD for a double-blind, placebo-controlled design to determine whether PEX010 (25-mg/d) shows preliminary …

Opioid Use Disorder

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Anna Rose Childress, Ph.D.NCT06786325